Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -26.59% is 48% below its 5-year average of -17.99%, near the low end of its 5-year range (-26.59%–-11.59%).
15.38% below its 12-month average of -23.05%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -5.72%.
RETURN ON ASSETS (ROA)
-26.59%
RETURN ON ASSETS (ROA) AVG TTM
-23.05%
RETURN ON ASSETS (ROA) AVG 3Y
-19.50%
RETURN ON ASSETS (ROA) AVG 5Y
-17.99%
RETURN ON ASSETS (ROA) AVG 10Y
-19.97%
RETURN ON ASSETS (ROA) AVG 15Y
-21.05%
RETURN ON ASSETS (ROA) AVG 20Y
-22.77%
CURRENT VS TTM AVG
-15.38%
CURRENT VS 3Y AVG
-36.38%
CURRENT VS 5Y AVG
-47.79%
CURRENT VS 10Y AVG
-33.18%
CURRENT VS 15Y AVG
-26.34%
CURRENT VS 20Y AVG
-16.76%
SECTOR MEDIAN · HEALTHCARE
-30.47%
median of 682 covered companies
CURRENT VS SECTOR MEDIAN
+12.73%
vs the sector median at left
MediciNova, Inc.
Market Cap
$83.18M
Return on Assets (ROA)
-26.59%
TTM Avg
-23.05%
3Y Avg
-19.50%
5Y Avg
-17.99%
Market Cap
$83.21M
Return on Assets (ROA)
-110.64%
TTM Avg
-124.68%
3Y Avg
-93.30%
5Y Avg
-78.61%
Market Cap
$83.04M
Return on Assets (ROA)
-74.91%
TTM Avg
-50.52%
3Y Avg
-40.48%
5Y Avg
-70.00%
Market Cap
$82.10M
Return on Assets (ROA)
49.88%
TTM Avg
-47.68%
3Y Avg
-37.92%
5Y Avg
-34.36%
Market Cap
$84.61M
Return on Assets (ROA)
-74.48%
TTM Avg
-208.94%
3Y Avg
-35981.57%
5Y Avg
-24064.76%
Market Cap
$84.86M
Return on Assets (ROA)
-43.13%
TTM Avg
-80.45%
3Y Avg
-58.18%
5Y Avg
-65.67%
Market Cap
$85.09M
Return on Assets (ROA)
-70.05%
TTM Avg
-71.47%
3Y Avg
-58.80%
5Y Avg
-51.13%
Market Cap
$80.89M
Return on Assets (ROA)
-41.09%
TTM Avg
-24.80%
3Y Avg
-25.41%
5Y Avg
-25.41%
Market Cap
$85.55M
Return on Assets (ROA)
-107.29%
TTM Avg
-60.42%
3Y Avg
-51.23%
5Y Avg
-39.69%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MediciNova, Inc. (MNOV) | $83.18M | -26.59% | -23.05% | -19.50% | -17.99% |
| Nutriband Inc. (NTRB)vs › | $83.21M | -110.64% | -124.68% | -93.30% | -78.61% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $83.04M | -74.91% | -50.52% | -40.48% | -70.00% |
| LENSAR Inc (LNSR)vs › | $82.10M | 49.88% | -47.68% | -37.92% | -34.36% |
| ProMIS Neurosciences, Inc. (PMN)vs › | $84.61M | -74.48% | -208.94% | -35981.57% | -24064.76% |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.86M | -43.13% | -80.45% | -58.18% | -65.67% |
| Humacyte, Inc. (HUMA)vs › | $85.09M | -70.05% | -71.47% | -58.80% | -51.13% |
| Citius Oncology, Inc. (CTOR)vs › | $80.89M | -41.09% | -24.80% | -25.41% | -25.41% |
| Cardiff Oncology, Inc. (CRDF)vs › | $85.55M | -107.29% | -60.42% | -51.23% | -39.69% |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $85.81M | -79.38% | 41.63% | -36.06% | -44.84% |
ROA
-26.6%
ROE
-28.9%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -26.31% |
| 2024-12-31 | -19.78% |
| 2023-12-31 | -12.93% |
| 2022-12-31 | -18.97% |
| 2021-12-31 | -11.59% |
| 2020-12-31 | -18.37% |
| 2019-12-31 | -16.34% |
| 2018-12-31 | -19.00% |
| 2017-12-31 | -25.71% |
| 2016-12-31 | -27.29% |
| 2015-12-31 | -23.33% |
| 2014-12-31 | -33.72% |
| 2013-12-31 | -13.63% |
| 2012-12-31 | -56.02% |
| 2011-12-31 | -57.60% |
| 2010-12-31 | -27.68% |
| 2009-12-31 | -21.59% |
| 2008-12-31 | -43.65% |
| 2007-12-31 | -66.31% |
| 2006-12-31 | -31.98% |
| 2005-12-31 | -18.04% |
| 2004-12-31 | -89.78% |
| 2003-12-31 | -110.26% |
| 2002-12-31 | -437.01% |
| 2001-12-31 | -21.42% |
